Harte Hanks Acquires Exclusive Rights to License ADS Data Direct's Premier Medical Ailment Database

Rhea-AI Summary

Harte Hanks (NASDAQ:HHS) has secured exclusive licensing rights to ADS Data Direct's Medical Ailment Database, a comprehensive HIPAA-compliant health data asset. The database, sourced through the Healthier Me Today platform, contains self-reported health information from triple opt-in consumers across 200+ ailment categories including diabetes, arthritis, heart disease, and mental health disorders. This strategic acquisition strengthens Harte Hanks' position in healthcare marketing, enabling more precise targeting and improved campaign performance for pharmaceutical, medical device, and healthcare clients. The database's key feature is its reliability through HIPAA-compliant data collection processes, making it a valuable tool for healthcare marketers seeking ethical and effective consumer engagement.

Positive

• Exclusive licensing rights to a comprehensive health database covering 200+ ailment categories
• Access to 100% triple opt-in consumer data, ensuring high data quality and compliance
• Enhanced targeting capabilities for pharmaceutical and healthcare marketing campaigns
• Strengthened competitive position in the healthcare marketing sector

Negative

• Limited by certain client exceptions in the licensing agreement
• -

Insights

Data & Marketing Industry Analyst

Harte Hanks secures exclusive healthcare database rights, strengthening its competitive position in the lucrative, data-driven healthcare marketing sector.

This exclusive licensing agreement for ADS Data Direct's Medical Ailment Database represents a strategic competitive advantage for Harte Hanks in the healthcare marketing landscape. The database's key strength lies in its collection of self-reported health information across over 200 ailment categories from consumers who have provided triple opt-in consent—meaning they've confirmed their willingness to share their data multiple times, creating an exceptionally compliant foundation for targeted marketing.

The healthcare marketing sector is particularly valuable because pharmaceutical and medical companies typically maintain substantial marketing budgets even during economic downturns. By securing exclusive access to this database (with limited exceptions), Harte Hanks has effectively created a moat around its healthcare marketing capabilities that competitors cannot easily replicate.

This move aligns perfectly with the broader industry shift toward first-party, consent-based data as privacy regulations tighten globally. The HIPAA-compliant nature of this database addresses a critical challenge in healthcare marketing: balancing targeting precision with regulatory compliance. For clients in pharmaceuticals and medical devices, this translates to more efficient campaign targeting and potentially improved marketing ROI.

While the press release doesn't disclose financial terms of the licensing agreement, the strategic value is clear. As third-party cookies phase out and data privacy concerns intensify, proprietary data assets like this database become increasingly valuable competitive differentiators. This acquisition reflects Harte Hanks' forward-thinking approach to securing high-quality, compliant data assets that both address current market challenges and create new revenue opportunities in specialized marketing services.

Strategic Licensing Rights Strengthen Harte Hanks' Leadership in Compliant, High-Precision Healthcare Marketing

CHELMSFORD, MA / ACCESS Newswire / June 2, 2025 / Harte Hanks (NASDAQ:HHS), a global leader in customer experience and data-driven marketing, today announced that it has obtained exclusive rights to license ADS Data Direct's (ADS) industry-leading Medical Ailment Database, with limited client exceptions. This transformative undertaking positions Harte Hanks as the controller of one of the most comprehensive, HIPAA-compliant health data assets available in the market, delivering unmatched value to healthcare marketers.

ADS's Medical Ailment Database, sourced through the Healthier Me Today platform, provides access to 100% triple opt-in consumers who have self-identified as living with specific health conditions across more than 200 ailment categories. This valuable data asset enhances Harte Hanks' ability to deliver superior targeting precision, campaign performance, and compliance assurance for clients in the pharmaceutical, medical device, and broader healthcare sectors.

"The exclusive licensing right to this high-integrity database is a strategic milestone for Harte Hanks, deepening our commitment to delivering unparalleled data solutions that empower healthcare and health-related marketers," said Teresa Gavin, VP of Data Solutions at Harte Hanks. "We are now better positioned than ever to help our clients engage the right consumers-ethically, effectively, and with measurable impact."

The Medical Ailment Database is distinguished by its depth and reliability, capturing self-reported health data through rigorous HIPAA-compliant processes on the Healthier Me Today platform. It is purpose-built to support campaigns targeting individuals managing conditions such as diabetes, arthritis, heart disease, mental health disorders, and many more.

ADS is a premium provider of precision-targeted marketing solutions, offering proprietary data assets that drive scalable lead generation and engagement strategies across digital, mobile, email, and direct mail channels.

"Harte Hanks' licensing rights to our flagship health database reflects their vision and leadership in data-driven marketing," said Eric Nelson, President & Managing Partner of ADS Data Direct. "We are confident that their expertise and strategic focus will unlock the full potential of this asset, delivering exceptional value to healthcare and health-related marketers."

For media inquiries or to learn more about the Medical Ailment Database, please contact:
Cindy Stein
Global Head of Marketing
Harte Hanks
cindy.stein@hartehanks.com
www.HarteHanks.com

SOURCE: Harte Hanks, Inc.

View the original press release on ACCESS Newswire

FAQ

What did Harte Hanks (HHS) acquire in June 2025?

Harte Hanks acquired exclusive licensing rights to ADS Data Direct's Medical Ailment Database, a comprehensive health data asset covering over 200 ailment categories.

How does the ADS Data Direct database benefit Harte Hanks?

The database enhances Harte Hanks' ability to deliver more precise targeting, improved campaign performance, and compliance assurance for healthcare marketing clients.

What types of health conditions does the Medical Ailment Database cover?

The database covers over 200 ailment categories including diabetes, arthritis, heart disease, and mental health disorders.

How is the data in ADS Data Direct's Medical Ailment Database collected?

The data is collected through the Healthier Me Today platform using a HIPAA-compliant process with 100% triple opt-in consumers who self-identify their health conditions.

What industries will benefit from Harte Hanks' new database licensing rights?

The pharmaceutical, medical device, and broader healthcare sectors will benefit from this database for their marketing campaigns.